Trial Profile
The Effects of Withdrawing the Alpha-1 Blocker from Alpha-1 Blocker plus 5-Alpha-Reductase Inhibitor Combination Therapy on Patients with Benign Prostatic Hyperplasia from the Perspective of Urodynamics Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2015
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary) ; Silodosin
- Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
- Focus Therapeutic Use
- 05 Nov 2015 New trial record
- 09 Oct 2015 Results presented at the 45th Annual Meeting of the International Continence Society